Xeno Transplants Stock Today

XENO Stock  USD 0.0001  0.00  0.00%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 30

 
High
 
Low
Below Average
Xeno Transplants is selling at 1.0E-4 as of the 11th of December 2024; that is No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Xeno Transplants has about a 30 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of November 2024 and ending today, the 11th of December 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Xeno Transplants Corporation operates as a bio-technology research and development company. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts. XENO TRANSPLANTS is traded on PNK Exchange in the United States. More on Xeno Transplants

Xeno Stock Highlights

CEOElliot Lebowitz
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Xeno Transplants (XENO) is traded on OTCCE Exchange in USA and employs 2 people. Xeno Transplants is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 64.58 K. Xeno Transplants conducts business under Biotechnology sector and is part of Health Care industry. Xeno Transplants currently holds about 261 in cash with (6.56 K) of positive cash flow from operations.
Check Xeno Transplants Probability Of Bankruptcy

Xeno Stock Against Markets

Already Invested in Xeno Transplants?

The danger of trading Xeno Transplants is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Xeno Transplants is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Xeno Transplants. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Xeno Transplants is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Xeno Transplants offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xeno Transplants' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xeno Transplants Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xeno Transplants Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xeno Transplants. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Xeno Stock, please use our How to Invest in Xeno Transplants guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xeno Transplants. If investors know Xeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xeno Transplants listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xeno Transplants is measured differently than its book value, which is the value of Xeno that is recorded on the company's balance sheet. Investors also form their own opinion of Xeno Transplants' value that differs from its market value or its book value, called intrinsic value, which is Xeno Transplants' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xeno Transplants' market value can be influenced by many factors that don't directly affect Xeno Transplants' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xeno Transplants' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xeno Transplants is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xeno Transplants' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.